18 THUMBS UP: FDA advisers vote 18-4 to recommend the agency approve sales of lorcaserin, which could be the country's first new prescription diet drug in over a decade.
STOCK SURGE: Shares nearly doubled in after-hours trading, as lorcaserin could become the small company's first approved product.
NEXT STEPS: Maker Arena Pharmaceuticals says it will work with the FDA as it finishes its review, with a June 27 target for a final decision. The agency had rejected lorcaserin in 2010 over possible heart risks, but Arena tried again with additional data.
Doug Fabian - This Real Estate ETF Could be a Home for Your Money
What the heck is going on in the Maryland Senate race?
'Clarence Thomas' trends as liberals update their wish lists
The Craziest GOP Debate of The Cycle: Trump Defends Planned Parenthood, Cruz and Rubio Spar, Audience Boos
Is Titanium Bulletproof?
New Jersey Man Slays Child | Human Events
Winners and Losers from Tonight’s CBS GOP Debate | RedState